SCHEMBL3775779

SCHEMBL3775779

O=Cc1ccc2c(c1)C(=O)N(O)C2=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
PTGS2 P35354 1/20 0.42
RAB9A P51151 1/20 0.42
ERCC1 P07992 2/20 0.38
FEN1 P39748 2/20 0.38
ERCC4 Q92889 2/20 0.38
CYP2A6 P11509 3/20 0.38
RXFP1 Q9HBX9 1/20 0.38
ALDH1A1 P00352 6/20 0.38
ALDH1A3 P47895 3/20 0.37
ALDH5A1 P51649 2/20 0.37
ABAT P80404 2/20 0.37
TDP1 Q9NUW8 2/20 0.36
TSHR P16473 2/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
ALOX12 P18054 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TRIM24 O15164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10707787 0.77 ESR1 (0.53) KDM4ERAB9AALDH1A1TSHRPOLB
SCHEMBL14446705 0.76 POLB (0.54) KDM4ERAB9ACYP2A6RXFP1ALDH1A1
SCHEMBL10706567 0.75 ESR1 (0.70) RAB9AALDH1A1ALDH5A1ABATTSHR
SCHEMBL8605222 0.74 ESR1 (0.60) KDM4EALDH1A1MAPTSMN1; SMN2HPGD
SCHEMBL25060901 0.74 KDM4E (0.57) KDM4ERAB9AERCC1FEN1ERCC4
SCHEMBL2663010 0.73 HSD17B10 (0.54) KDM4EALDH1A1MAPTSMN1; SMN2HPGD
SCHEMBL12239455 0.73 ALDH1A1 (0.61) RAB9ACYP2A6ALDH1A1TSHRPOLB
SCHEMBL7900508 0.72 ESR1 (0.62) ESR1ESR2
SCHEMBL10630774 0.72 ESR1 (0.72) KDM4ERAB9AALDH1A1POLBMAPT
SCHEMBL12534799 0.72 TDP1 (0.41) KDM4ERAB9AERCC1FEN1ERCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317869-A1 IMMOBILIZED CYCLIC IMIDE CATALYST AND PROCESS FOR OXIDATION OF ORGANIC COMPOUNDS WITH THE SAME DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2010-12-16 US disclosed
EP-2116303-A1 IMMOBILIZED CYCLIC IMIDE CATALYST AND PROCESS FOR OXIDATION OF ORGANIC COMPOUNDS WITH THE SAME Daicel Chemical Industries, Ltd. (JP) 2009-11-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317869-A1 IMMOBILIZED CYCLIC IMIDE CATALYST AND PROCESS FOR OXIDATION OF ORGANIC COMPOUNDS WITH THE SAME AOC2, NOXO1, NOX1 KDM4E 678/4885PTGS2 1280/4885RAB9A 3889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.